Document Detail

Dilemmas in treatment of women with familial hypercholesterolaemia during pregnancy.
MedLine Citation:
PMID:  20739726     Owner:  NLM     Status:  In-Process    
Familial hypercholesterolaemia (FH) is a co-dominant monogenic disorder of lipoprotein metabolism, characterised by severely elevated levels of low-density lipoprotein cholesterol (LDL-C) from birth onwards. Treatment of FH patients with cholesterol-lowering medication is mandatory to prevent premature cardiovascular disease (CVD). As a result of a nationwide screening in the Netherlands, a large group of women with FH in the child-bearing age range has been identified. Physicians are faced with a treatment dilemma if these females present either with a wish for pregnancy or an established pregnancy, since all systemically absorbed lipid-lowering medication is contraindicated during pregnancy. Currently, no evidence-based guidelines exist on the optimal clinical approach in these patients. Animal studies have shown conflicting data on potential teratogenicity of statins. In humans, there is no strong adverse safety signal, but prospective studies are lacking. The consequences of maternal hypercholesterolaemia during pregnancy for both mother and child are not well determined, although it has been suggested that it may increase the risk of CVD in the offspring. This review describes two representative cases from clinical practice, and discusses clinical considerations for treating pregnant FH patients supplemented with what is known from the literature.
D M Kusters; S J M Homsma; B A Hutten; M T B Twickler; H J Avis; J A van der Post; E S G Stroes
Related Documents :
14607576 - Violence does not influence early pregnancy loss.
7597466 - Attributions for disability: the influence of genetic screening.
12138936 - The meaning of sexual satisfaction in pregnant taiwanese women.
15733266 - A randomized trial comparing alternative approaches to prenatal diagnosis counseling in...
910156 - Screening for twin pregnancy.
8735006 - Multiple pregnancies: the price to pay.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  The Netherlands journal of medicine     Volume:  68     ISSN:  1872-9061     ISO Abbreviation:  Neth J Med     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0356133     Medline TA:  Neth J Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  299-303     Citation Subset:  IM    
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Thalidomide and lenalidomide in primary myelofibrosis.
Next Document:  Novel therapies for hypereosinophilic syndromes.